Evidence suggests reactivations of the varicella-zoster virus may accelerate aging and raise dementia risk. Now scientists want to know if vaccines and antivirals could help protect the brain.
Gilead has handed back a next-gen hepatitis B antiviral to Assembly Biosciences, while the two companies continue to partner ...
The FDA has previously granted fast track designation to aglatimagene plus valacyclovir in combination with ICI therapy for the treatment of patients with stage III/IV NSCLC who are resistant to first ...
(MENAFN- GlobeNewsWire - Nasdaq) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media ...
Meningitis, particularly bacterial meningitis, can be deadly if left untreated: according to the World Health Organization, around one in six people affected by this type of meningitis die, and ...
The UK Health Security Agency (UKHSA) said that as of 5pm on Wednesday, 15 cases of meningitis have been confirmed and a ...
Glasgow Times on MSN
My son almost died from meningitis but these quick actions saved his life
Gaynor Simpson faced every parents' worst nightmare when her son was left fighting for his life with sepsis and meningitis ...
The table below is a review of notable updates that occurred in February 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.
A federal court injunction put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and misinformation have sown doubt about ...
A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think ...
Researchers at the George Washington University School of Medicine and Health Sciences in partnership with Baylor College of Medicine report encouraging results from a phase 2 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results